Seven Grand Managers’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
Seven Grand Managers's BIOA Position: Q3 2026 in Review
Seven Grand Managers sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 50,000 shares — an estimated $1.23M sold.
Seven Grand Managers first reported a position in BIOA in Q1 2026 and held it in 2 quarters. The position peaked at $1.23M in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- Seven Grand Managers reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
- Seven Grand Managers sold 50,000 BioAge Labs shares in Q3 2026, an estimated $1.23M.
- Seven Grand Managers first reported a position in BioAge Labs in Q1 2026 and held it in 2 quarters.
- Seven Grand Managers's BioAge Labs position peaked at $1.23M in Q2 2026.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.